Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol versus Foley catheter for cervical ripening in hypertensive pregnancy
IRCT20090525001946N12Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in maternal hypertension (HDP), preeclampsia and pregnancy-induced hypertension (PIH) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Cervical ripening success and Duration of cervical ripening. Started Jan 2025; status: completed.
02
Drugs
misoprostol
03
Conditions
maternal hypertension (HDP)preeclampsiapregnancy-induced hypertension (PIH)
Beyond the preview
Go deeper on IRCT20090525001946N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090525001946N12.